A teenager's innovative paper sensor for early pancreatic cancer detection, based on the protein mesothelin, captured global attention. While the concept addressed a critical medical need for affordable, accessible diagnostics, experts emphasize that scientific promise doesn't equate to clinical validation. The story highlights the ongoing challenge of developing reliable cancer screening tools.